Jaap M Middeldorp Selected Research

Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)

11/2021

PCR-Free Shallow Whole Genome Sequencing for Chromosomal Copy Number Detection from Plasma of Cancer Patients Is an Efficient Alternative to the Conventional PCR-Based Approach.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jaap M Middeldorp Research Topics

Disease

32	Neoplasms (Cancer) 01/2023 - 05/2002
26	Nasopharyngeal Carcinoma 09/2023 - 05/2002
10	Epstein-Barr Virus Infections 01/2022 - 01/2003
9	Carcinoma (Carcinomatosis) 03/2018 - 08/2002
7	Infections 01/2022 - 02/2002
6	Lymphoma (Lymphomas) 06/2011 - 07/2005
5	Malaria 01/2022 - 06/2009
5	Infectious Mononucleosis (Glandular Fever) 11/2018 - 10/2003
4	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2019 - 06/2009
4	Hodgkin Disease (Hodgkin's Disease) 08/2016 - 05/2002
3	Carcinogenesis 01/2017 - 12/2009
2	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 01/2017 - 04/2012
2	Inflammation (Inflammations) 01/2017 - 02/2016
2	Latent Infection 02/2016 - 02/2002
2	Pathologic Complete Response 11/2006 - 01/2002
1	Persistent Infection 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2021
1	B-Cell Lymphoma (Lymphoma, B Cell) 11/2021
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2021
1	Coinfection 01/2019
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2019
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2017
1	Tetanus 11/2015
1	Falciparum Malaria (Plasmodium falciparum Malaria) 11/2015
1	Necrosis 01/2015
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 12/2014
1	Parkinson Disease (Parkinson's Disease) 07/2014
1	Parasitemia 03/2012
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 02/2011
1	Starvation 10/2010
1	Multiple Sclerosis 09/2010
1	Hypoxia (Hypoxemia) 12/2009

Drug/Important Bio-Agent (IBA)

20	Proteins (Proteins, Gene)FDA Link 01/2023 - 11/2002
16	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 08/2002
13	Immunoglobulin A (IgA)IBA 09/2023 - 07/2004
13	AntibodiesIBA 01/2023 - 11/2002
11	Immunoglobulin G (IgG)IBA 01/2023 - 07/2004
10	AntigensIBA 01/2022 - 05/2002
9	RNA (Ribonucleic Acid)IBA 01/2019 - 02/2002
6	EBV-encoded nuclear antigen 1IBA 01/2022 - 05/2002
5	MicroRNAs (MicroRNA)IBA 01/2019 - 04/2010
5	Membrane Proteins (Integral Membrane Proteins)IBA 01/2014 - 05/2002
4	Epstein-Barr virus encoded RNA 1IBA 01/2017 - 08/2002
4	Viral DNAIBA 01/2017 - 05/2011
4	Messenger RNA (mRNA)IBA 01/2017 - 07/2005
4	EnzymesIBA 05/2009 - 08/2002
3	VaccinesIBA 01/2019 - 10/2009
3	Antiviral Agents (Antivirals)IBA 11/2018 - 02/2002
3	Peptides (Polypeptides)IBA 08/2016 - 10/2010
2	Glycoproteins (Glycoprotein)IBA 01/2023 - 10/2009
2	Immunoglobulins (Immunoglobulin)IBA 01/2023 - 07/2004
2	Immunoglobulin M (IgM)IBA 01/2022 - 10/2010
2	Merozoite Surface Protein 1 (MSA1)IBA 01/2022 - 07/2010
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2012
2	Viral ProteinsIBA 12/2019 - 12/2017
2	Histone Deacetylases (Histone Deacetylase)IBA 01/2016 - 12/2014
2	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2015 - 10/2010
2	ImmunosorbentsIBA 05/2009 - 11/2002
2	Nuclear Antigens (Extractable Nuclear Antigens)IBA 07/2004 - 01/2004
1	ProteomeIBA 01/2023
1	Complement System Proteins (Complement)IBA 01/2022
1	Heparin (Liquaemin)FDA LinkGeneric 11/2021
1	Edetic Acid (EDTA)FDA Link 11/2021
1	LithiumIBA 11/2021
1	Cell-Free Nucleic AcidsIBA 11/2021
1	Circulating MicroRNAIBA 01/2019
1	Tumor Biomarkers (Tumor Markers)IBA 01/2019
1	DiarylheptanoidsIBA 03/2018
1	fialuridineIBA 12/2017
1	InterferonsIBA 01/2017
1	Viral RNAIBA 01/2017
1	Indicators and Reagents (Reagents)IBA 01/2017
1	Histone Deacetylase InhibitorsIBA 01/2016
1	romidepsin (FK228)FDA Link 01/2016
1	Protein Isoforms (Isoforms)IBA 01/2016
1	Epstein-Barr Virus Nuclear AntigensIBA 11/2015
1	Tumor Necrosis Factor Receptor-Associated Peptides and ProteinsIBA 01/2015
1	Proteasome InhibitorsIBA 12/2014
1	Bortezomib (Velcade)FDA Link 12/2014
1	SynucleinsIBA 07/2014
1	Small Interfering RNA (siRNA)IBA 10/2013
1	NF-kappa B (NF-kB)IBA 10/2013
1	Cyclin D1IBA 10/2013
1	Vorinostat FDA Link 10/2012
1	Gemcitabine FDA Link 09/2012
1	Ganciclovir (Cytovene)FDA LinkGeneric 09/2012
1	Valproic Acid (Depakote)FDA LinkGeneric 09/2012
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 02/2011
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2010
1	Transforming Growth Factor beta (TGF-beta)IBA 10/2010
1	Hypoxia-Inducible Factor 1IBA 12/2009
1	Epstein-Barr virus EBV-associated membrane antigenIBA 12/2009
1	Oxygen (Dioxygen)IBA 12/2009

Therapy/Procedure

5	Therapeutics 12/2017 - 11/2006
2	Drug Therapy (Chemotherapy) 01/2014 - 11/2006
2	Radiotherapy 01/2014 - 11/2006
2	Aftercare (After-Treatment) 04/2013 - 01/2002
1	Chemoradiotherapy 01/2014
1	Transplantation 10/2009
1	Injections 10/2009